Author

Chuong Nguyen

Primary ORCID profile (0000-0001-8373-981X · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Chuong NguyeniD2 papers · Pfizer (United States)

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Amelia CasamassimiiD· 1 shared Brad Niles· 1 shared Ciro AbbondanzaiD· 1 shared Marzia Di DonatoiD· 1 shared Maya Chaturvedi· 1 shared Md. Zubbair MalikiD· 1 shared Mohit MishraiD· 1 shared Nicole N. Nuñez· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amelia CasamassimiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

siRNA-based Therapeutic Candidate Targeting PRDM2 for Inhibition of Lung Cancer Progression

Sanjay Kumar, Md. Zubbair Malik, Maya Chaturvedi, Mohit Mishra, Marzia Di Donato, Amelia Casamassimi, Ciro Abbondanza, Patrizia Gazzerro, Chuong Nguyen, Nicole N. Nuñez, Somdutta Sen, Brad Niles, Rupesh Chaturvedi

This study identifies ARIZ-047, an siRNA targeting PRDM2/RIZ2, as a therapeutic candidate that inhibits lung cancer progression by increasing RIZ1 expression and suppressing Wnt signaling.

Biomedicine & Pharmacotherapy · Nov 23, 2025Peer-reviewedCancer Biology